Avadel Pharmaceuticals PLC (AVDL) — Cash Flow Quality Index
Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow Quality Index of 1162.99x as of September 2025. Operating cash flow of $23.26 Million exceeds net income of $20.00K, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Avadel Pharmaceuticals PLC generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Avadel Pharmaceuticals PLC Cash Flow Quality Index (2002–2020)
Historical Cash Flow Quality Index for Avadel Pharmaceuticals PLC across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Avadel Pharmaceuticals PLC to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Avadel Pharmaceuticals PLC (2002–2020)
Year-by-year earnings quality comparison for Avadel Pharmaceuticals PLC. For live market cap and the full company financial profile, see how much is Avadel Pharmaceuticals PLC worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | -6.93x | $-48.73 Million | $7.03 Million | ▼ -2898.9% |
| 2017 | 0.25x | $16.66 Million | $67.25 Million | ▼ -88.0% |
| 2015 | 2.07x | $84.29 Million | $40.66 Million | ▲ +724.4% |
| 2004 | -0.33x | $-4.15 Million | $12.50 Million | ▼ -111.4% |
| 2002 | 2.92x | $8.77 Million | $3.00 Million | — |